Cyanokit Europese Unie - Sloveens - EMA (European Medicines Agency)

cyanokit

serb sa - hidroksokobalamin - zastrupitev - vsi drugi terapevtski izdelki - zdravljenje znanih ali sumljivih zastrupitev s cianidi. cyanokit je treba dajati skupaj z ustreznimi dekontaminacijo in podporne ukrepe,.

Comirnaty Europese Unie - Sloveens - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Kanuma Europese Unie - Sloveens - EMA (European Medicines Agency)

kanuma

alexion europe sas - sebelipaza alfa - lipidna metabolizem, urogenitalne napake - drugi zdravljene bolezni prebavil in presnove izdelki, - kanuma je indiciran za dolgoročno encimsko nadomestno terapijo (ert) pri bolnikih vseh starosti z lizosomsko kislinsko lipazo (lal).

Brinavess Europese Unie - Sloveens - EMA (European Medicines Agency)

brinavess

correvio - vernakalant hidroklorid - atrijska fibrilacija - srčna terapija - hitro pretvorbo nedavni nastop atrijsko fibrilacijo, da sinus ritem pri odraslih:za ne-operaciji bolniki: atrijska fibrilacija .

Gencebok Europese Unie - Sloveens - EMA (European Medicines Agency)

gencebok

gennisium pharma - kofein citrat - apnea - psychoanaleptics, - zdravljenje primarne apnoea prezgodnje novorojenčkov.

Ovitrelle Europese Unie - Sloveens - EMA (European Medicines Agency)

ovitrelle

merck europe b.v. - horiogonadotropin alfa - anovulation; reproductive techniques, assisted; infertility, female - spolni hormoni in zdravila genitalni sistem, - ovitrelle je navedeno v zdravljenje:ženske, ki opravljajo superovulation pred oploditve z biomedicinsko tehnikah, kot je oploditev in vitro (ivf): ovitrelle se daje, da sproži končno folikularni zorenje in luteinisation po stimulacijo folikularni rast;anovulatory ali oligo-ovulatory ženske: ovitrelle se daje za sprožitev ovulacije in luteinisation v anovulatory ali oligo-ovulatory bolnikov po stimulacijo folikularni rast.

Insulin Human Winthrop Europese Unie - Sloveens - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - diabetes mellitus, kjer je potrebno zdravljenje z insulinom. insulin ljudi winthrop hitro je tudi primeren za zdravljenje hiperglikemično komi in ketoacidoze, kot tudi za doseganje pred, znotraj - in pooperativne stabilizacije pri bolnikih s sladkorno boleznijo.

Insuman Europese Unie - Sloveens - EMA (European Medicines Agency)

insuman

sanofi-aventis deutschland gmbh - insulin human - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - diabetes mellitus, kjer je potrebno zdravljenje z insulinom. insuman hitro je tudi primeren za zdravljenje hiperglikemično komi in ketoacidoze, kot tudi za doseganje pred, znotraj - in pooperativne stabilizacije pri bolnikih s sladkorno boleznijo.

Peyona (previously Nymusa) Europese Unie - Sloveens - EMA (European Medicines Agency)

peyona (previously nymusa)

chiesi farmaceutici spa - kofein citrat - apnea - psychoanaleptics, - zdravljenje primarne apnoea prezgodnje novorojenčkov.